2021
DOI: 10.3390/jcm10112451
|View full text |Cite
|
Sign up to set email alerts
|

Association between Skin Cancer and Systemic and Ocular Comorbidities in South Korea

Abstract: Background: In this study, we investigated the associations between various systemic and ocular comorbidities and skin cancer, in a nationwide cohort of South Koreans. Method: We reviewed the data of 1,103,302 individuals in the South Korean National Health Insurance Service-National Sample Cohort database from 2002 to 2015. Of these, 1202 individuals diagnosed with skin cancer from 2004 were included in the study group. The control group was matched in a 1:5 ratio based on propensity scores. Results: The prev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 38 publications
(50 reference statements)
0
1
0
Order By: Relevance
“…This study employed the subsequent comorbidities [ 24 , 25 ] as covariates for regression adjustment in order to mitigate potential confounding effects: Ischemic heart disease (ICD9: 414.01–414.9), Hypertension (ICD9: 401.1–405.99), Stroke (ICD9: 430–438), Diabetes mellitus (ICD9: 250.0–250.9), Abnormal liver function (ICD9: 790.4), Renal failure (ICD9: 584.9), GI bleeding (ICD9: 578.9), Hyperlipidemia (ICD9: 272.0–272.4), Chronic kidney diseases (ICD9: 585.1–585.9), COPD (Chronic Obstructive Pulmonary Disease) (ICD9: 491.21–491.22, 492.8, 496), Peptic ulcer (ICD9: 531.00–534.91), Gout (ICD9: 274.00–274.9).…”
Section: Methodsmentioning
confidence: 99%
“…This study employed the subsequent comorbidities [ 24 , 25 ] as covariates for regression adjustment in order to mitigate potential confounding effects: Ischemic heart disease (ICD9: 414.01–414.9), Hypertension (ICD9: 401.1–405.99), Stroke (ICD9: 430–438), Diabetes mellitus (ICD9: 250.0–250.9), Abnormal liver function (ICD9: 790.4), Renal failure (ICD9: 584.9), GI bleeding (ICD9: 578.9), Hyperlipidemia (ICD9: 272.0–272.4), Chronic kidney diseases (ICD9: 585.1–585.9), COPD (Chronic Obstructive Pulmonary Disease) (ICD9: 491.21–491.22, 492.8, 496), Peptic ulcer (ICD9: 531.00–534.91), Gout (ICD9: 274.00–274.9).…”
Section: Methodsmentioning
confidence: 99%